Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Severe COVID-19 may lower hemoglobin levels

Publish date:: April 15, 2020

Key clinical point: The hemoglobin value was significantly lower in severe COVID-19 patients, compared with those with milder forms.

Major finding: A weighted mean difference in hemoglobin content of −7.1 g/L (95% CI, −8.3 g/L to −5.9 g/L) was found in comparing severe to milder cases of COVID-19.

Study details: Meta-analysis of four studies of 1,210 COVID-19 patients with assessable hemoglobin values.

Disclosures: The authors declared that they had no conflicts of interest.

Citation:

Lippi G et al. Hematol Transfus Cell Ther. 2020 Apr 11; doi:10.1016/j.htct.2020.03.001.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Anemia

Emotions, worse attention linked to pain-related health care use SCD,

Oxidatative stress-related genetic variant tied to stroke risk in sickle cell patients,

Genetic variants may predict stroke in some adult SCD populations,

Severe COVID-19 may lower hemoglobin levels,

Low plasma sodium levels can predict complications in acute painful episodes of SCD,